Page last updated: 2024-10-25

cilostamide and Liver Cirrhosis

cilostamide has been researched along with Liver Cirrhosis in 1 studies

cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"Liver cirrhosis is associated with increased nitric oxide (NO) production in the vasculature."1.35PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization. ( Justiniano, H; Keravis, T; Lugnier, C; Maarouf, S; Sabra, R; Tahseldar-Roumieh, R, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tahseldar-Roumieh, R1
Keravis, T1
Maarouf, S1
Justiniano, H1
Sabra, R1
Lugnier, C1

Other Studies

1 other study available for cilostamide and Liver Cirrhosis

ArticleYear
PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization.
    International journal of experimental pathology, 2009, Volume: 90, Issue:6

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aorta; Bile Ducts; Cyclic Nucleotide Phosphodiesterase

2009